These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32866522)
21. Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis. Maji S; Chaudhary P; Akopova I; Nguyen PM; Hare RJ; Gryczynski I; Vishwanatha JK Mol Cancer Res; 2017 Jan; 15(1):93-105. PubMed ID: 27760843 [TBL] [Abstract][Full Text] [Related]
22. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells. Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450 [TBL] [Abstract][Full Text] [Related]
23. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling. Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785 [TBL] [Abstract][Full Text] [Related]
24. Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. Flister MJ; Tsaih SW; Stoddard A; Plasterer C; Jagtap J; Parchur AK; Sharma G; Prisco AR; Lemke A; Murphy D; Al-Gizawiy M; Straza M; Ran S; Geurts AM; Dwinell MR; Greene AS; Bergom C; LaViolette PS; Joshi A Breast Cancer Res Treat; 2017 Aug; 165(1):53-64. PubMed ID: 28567545 [TBL] [Abstract][Full Text] [Related]
25. ANXA2 expression in African American triple-negative breast cancer patients. Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786 [TBL] [Abstract][Full Text] [Related]
26. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
27. Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation. de Graauw M; Cao L; Winkel L; van Miltenburg MH; le Dévédec SE; Klop M; Yan K; Pont C; Rogkoti VM; Tijsma A; Chaudhuri A; Lalai R; Price L; Verbeek F; van de Water B Oncogene; 2014 May; 33(20):2610-9. PubMed ID: 23792445 [TBL] [Abstract][Full Text] [Related]
28. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927 [TBL] [Abstract][Full Text] [Related]
29. DDR1 promotes breast tumor growth by suppressing antitumor immunity. Zhong X; Zhang W; Sun T Oncol Rep; 2019 Dec; 42(6):2844-2854. PubMed ID: 31578591 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis. Jin K; Pandey NB; Popel AS Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755 [TBL] [Abstract][Full Text] [Related]
31. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells. Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457 [TBL] [Abstract][Full Text] [Related]
32. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Sharma M; Ownbey RT; Sharma MC Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer. Wu J; Sun Z; Sun H; Li Y Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608 [TBL] [Abstract][Full Text] [Related]
34. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733 [TBL] [Abstract][Full Text] [Related]
35. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797 [TBL] [Abstract][Full Text] [Related]
36. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis. Karginova O; Weekley CM; Raoul A; Alsayed A; Wu T; Lee SS; He C; Olopade OI Mol Cancer Ther; 2019 May; 18(5):873-885. PubMed ID: 30824611 [TBL] [Abstract][Full Text] [Related]
38. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2. Chen H; Pan H; Qian Y; Zhou W; Liu X Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680 [TBL] [Abstract][Full Text] [Related]
39. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. D'Ippolito E; Plantamura I; Bongiovanni L; Casalini P; Baroni S; Piovan C; Orlandi R; Gualeni AV; Gloghini A; Rossini A; Cresta S; Tessari A; De Braud F; Di Leva G; Tripodo C; Iorio MV Cancer Res; 2016 Sep; 76(18):5562-72. PubMed ID: 27402080 [TBL] [Abstract][Full Text] [Related]
40. Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers. Mahdi AF; Malacrida B; Nolan J; McCumiskey ME; Merrigan AB; Lal A; Tormey S; Lowery AJ; McGourty K; Kiely PA Cells; 2020 Jun; 9(7):. PubMed ID: 32629869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]